Oric Pharmaceuticals, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D/A: SR One Capital Reduces ORIC Pharma Stake Below 5%
SR One Capital Management and its affiliated funds have reported a decrease in their beneficial ownership of ORIC Pharmaceuticals, Inc. common stock to below 5%.
NASDAQ
SCHEDULE 13D: SR One Capital Management Funds Acquire 5.4% Stake in ORIC Pharmaceuticals Through Private Placement
SR One Capital Management and its affiliated funds have acquired a significant 5.4% beneficial ownership stake in ORIC Pharmaceuticals, Inc. through a recent private placement of common stock and pre-funded warrants.